ROYAL BANK OF CANADA - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is and the CUSIP is 00430K873. A total of 10 filers reported holding ACASTI PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2023$2,0000.0%3,5100.0%0.00%
Q1 2023$2,000
+100.0%
3,510
+105.7%
0.00%
Q4 2022$1,0000.0%1,706
+55.0%
0.00%
Q3 2022$1,0001,101
+178.7%
0.00%
Q2 2022$0395
+74.0%
0.00%
Q1 2022$0
-100.0%
227
-89.2%
0.00%
Q4 2021$3,000
+50.0%
2,107
+120.6%
0.00%
Q3 2021$2,0009550.00%
Other shareholders

There were no reported owners of ACASTI PHARMA INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of ACASTI PHARMA INC shareholders